FBL blood test as a predictive marker of breast cancer in high risk women

Medical Oncology

Volumn 14, Issue 1, 1997, Pages 39-42

  Moroz, Chaya ^a   Chetrit, Angela ^b   Kahn, Moshe ^a   Modan, Baruch ^b,c  

^a RABIN MEDICAL CENTER   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Breast cancer; FBL; Prognosis; Screening

Indexed keywords

FERRITIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; DIAGNOSTIC VALUE; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; LYMPHOCYTE; PRIORITY JOURNAL;

EID: 0030871414     PISSN: 07360118     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02990944     Document Type: Article

References (19)

1. Moroz, C. and Bessler, H. (1989) Ferritin as a marker for malignancy. In: De-Sousa, M, and Brock, J. (eds.) Ferritin in Immunity, Cancer and Inflammation, pp. 283-301. New York: Wiley and Sons.
2. Rosen, H.R., Flex, D., Stierer, M. and Moroz, C. (1991) Monoclonal antibody cM-H-9 detects circulating placental isoferritin in the serum of patients with visceral metastases of breast cancer. Cancer Lett. 59, 145-51.
3. Moroz, C., Kupfer, B., Twig, S. and Parhami-Seren, B. (1985) Preparation and characterization of monoclonal antibodies specific to placenta ferritin. Clin. Chim. Acata. 148, 111-7.
4. Shierman, N., Kupfer, B. and Moroz, C. (1991) Comparison of transferrin receptors, iron content and isoferritin profile in normal and malignant human breast cell lines. Pathobiology 59, 19-25.
5. Moroz, C., Giler, Sh., Kupfer, B. and Urea, J. (1977) Lymphocyte bearing surface ferritin in patients with Hodgkin's disease and breast cancer. N. Engl. J. Med. 296, 1173.
6. Moroz, C., Giler, Sh., Kupfer, B. and Urea, J. (1977) Ferritin-bearing lymphocytes and T-cells in peripheral blood of patients with breast cancer. Cancer Immunol Immunother. 3, 101-5.
7. Koprivova, H., Hermanska, Z., Novak, F., Blehova, Z. and Dienstbier, Z. (1988) Ferritin bearing lymphocytes in Hodgkin's disease. Neoplasma 33, 63-9.
8. Papenhausen, P.R., Emeson, E.E., Croft, C.B. and Borowiecki, B. (1984) Ferritin bearing lymphocytes in patients with cancer. Cancer 53, 267-71.
9. Rosen, H.R., Stierer, M., Gottlicher, I. et al. (1992) Determination of placental ferritin (PCF) positive lymphocytes in women with early stages of breast cancer. Int. J. Cancer 52, 229-33.
10. Rosen, H., Sherer, M., Gottlicher, J., Wolf, H. and Spoula, H. (1993) Determination of placental ferritin-positive peripheral lymphocytes in early stages of breast cancer. Am. J. Snrg. 165, 213-7.
11. Moroz, C., Kahn, M., Chaimoff, C., Marcus, H., Kupfer, B. and Cuckle, S. (1984) Ferritin-bearing lymphocytes in the diagnosis of breast cancer. Cancer 54, 84-9.
12. Moroz, C., Kahn, M., Ron, E., Luria, H. and Chaimoff, C. (1989) The use of oncofetal ferritin-bearing lymphocytes as a marker for the screening, diagnosis and follow-up of patients with early breast malignancy screening of 3400 women. Cancer 64, 691-7.
13. Dixon, W.J., Brown, M.B., Engelman, K., Jennzich, R.I. (1990) BMDP Statistical Software Vol. 1, (Revision).
14. Boice, J. Jr, Pickle, L. and Thomas T. (1991) Observed versus Expected Events. Epidemiology and Biostatics Program. NCI.
15. Rosen, H.R., Moroz, C., Reiner, A. et al. (1992) Expression of p43 in breast cancer tissue, correlation with prognostic parameters. Cancer Lett. 67, 35-45.
16. Daly, L., Ferguson, J., Gram, G.P. et al. (1992) Comparison of a novel assay for breast cancer mucin to Ca 54 153 and carcinoembryonic antigen. J. Clin. Oncol. 10, 1057-65.
17. Demers, L.M., Harvey, H.A., Glenn, J.D. and Gaur, P.K. (1988) Ca 549: a new tumor marker for patients with advanced breast cancer. J. Clin. Lab. Anal. 2, 168-73.
18. Duistrian, A.M., Schwartz, M.K., Greenberg, E.J., Smith, C.A. and Schwartz, D.C. (1991) Evaluation of Ca M26, Ca M29, Ca 153 and CEA as circulating tumor markers in breast cancer patients. Tumor Biol. 12, 82-90.
19. Werner, M., Faser, Ch. and Silverberg, M. (1993) Clinical utility and validation of emerging biochemical markers for mammary adenocarcinoma. Clin. Chem. 39/11(B), 2386-96.